Ananya C Nanduri DO

[Am J Trop Med Hyg @AJTMH]

Case Report: A Fatal Case of Latent #Melioidosis Activated by #COVID19 https://t.co/ZsaNbKEOdG @udaygulati @nanduria1 @inspirameded @junejaprateek @ASTMH

[Ananya C Nanduri DO @nanduria1]

Such a good case this morning! Amazing discussion by our residents @InspiraMeded and that illness script is bomb @udaygulati. 👍🏼

[InspiraIM_Vineland @InspiraIM]

1/ Another insightful and humbling case today for our new #ClinicalProblemSolvingSeries. Thank you @CPSolvers & #medtwitter for the inspiration. #FOAMed. Amazing job by our PGY discussants in solving this case, organized by @udaygulati . Here it is:

[Ananya C Nanduri DO @nanduria1]

Yes! Order and look at blood smears, they’re so incredibly helpful!
Watch me check copper levels on everyone now ;)
@runthelistpod

[RunTheList @runthelistpod]

Episode 44: Pancytopenia is now out!

Dr. Aric Parnes chats with host Joyce Zhou @joycezhou27 & script writer/case presenter Sarah Onorato @sonorato11

--
🍎 podcasts: https://t.co/XAmOZZ1jZ2
Spotify: https://t.co/L7JnDKsDrA
RTL 🕸️: https://t.co/wPSel58WGv

#FOAMed #MedEd

[Ananya C Nanduri DO @nanduria1]

@InspiraMeded I don’t think there’s a benefit to placing a patient on prophylaxis. More testing needs to be completed - the 4.2% versus 10.2% VTE in AVERT trial is significant and needs more testing. I also don’t think routine US is indicated. /2

[Ananya C Nanduri DO @nanduria1]

@InspiraMeded Certainly, specific agents have an increased VTE risk such as TKIs, Thalidomide agents, VEGF inhibitors, Tamoxifen, Platinum agents so the type of cancer and the agent will definitely play a role in risk of VTE. /1

[Ananya C Nanduri DO @nanduria1]

Both a fun and educational discussion yesterday with @InspiraMeded, @JunejaPrateek, @udaygulati, @AndrewMarcanoDO. 👍🏼 #HemeOnc

[InspiraIM_Vineland @InspiraIM]

1/ Yesterday at #JournalClub, we discussed AVERT and CASSINI trials, apixaban and rivaroxaban, respectively, for VTE prophylaxis in patients undergoing chemo. #HemeOncTwitter #Medtwitter @MedTweetorials

[Ananya C Nanduri DO @nanduria1]

Easy to follow breakdown and approach to thrombocytopenia. Thank you for another fantastic episode!

[RunTheList @runthelistpod]

Episode 43: Thrombocytopenia is now out!

Dr. Robert Stern chats w/ host Dr. Navin Kumar @NavinKumarMD & script writer/case presenter Sara Onorato @sonorato11

--
🍎podcasts: https://t.co/XAmOZZ1jZ2
Spotify: https://t.co/L7JnDKsDrA
RTL🕸️: https://t.co/NP5rNE4glY

#FOAMed #MedEd

[InspiraIM_Vineland @InspiraIM]

New post on the #MedEd blog by @nanduria1 ! How do you work up a CODE CVA? #medtwitter #FOAMed https://t.co/hrLs2yZI8b

[InspiraIM_Vineland @InspiraIM]

#SignOutPearls are back on the #MedEd blog! What are the indications for a permanent pacemaker? #FOAMed #MedTwitter #Cardiotwitter https://t.co/5cm4ha7Xaz

[InspiraIM_Vineland @InspiraIM]

Part II OF FUO🕵️ #SignOutPearls on the #Meded Blog: How do you work-up FUO❔❓ #MedTwitter #FOAMed
https://t.co/wO2C0x3Va5

[InspiraIM_Vineland @InspiraIM]

Let's make the unknown known. 🕵️ #SignOutPearls on the #MedEd blog: how do you define Fever of Unknown Origin❓❔ #MedTwitter #FOAMed
https://t.co/yEdgxAHbTs

[InspiraIM_Vineland @InspiraIM]

New #SignOutPearls on the #MedEd blog: What drugs are being investigated for #COVID19? #MedTwitter #FOAMed https://t.co/YhabPZfCyb

[Ananya C Nanduri DO @nanduria1]

@MarkGSunga Hahaha yes! It definitely reinforces the learning!